NCT05008354View on ClinicalTrials.gov

Effect of Pyridoxine on Behavioral Adverse Events of Levetiracetam

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 1, 2020

Primary Completion Date

September 1, 2021

Study Completion Date

September 1, 2021

Conditions
EpilepsyPyridoxineBehavior Problem
Interventions
DRUG

Pyridoxine

Pyridoxine tablet 40mg once daily

DRUG

Placebo

Placebo tablet once daily

Trial Locations (1)

4815837477

Bu Ali Sina Hospital, Sari

All Listed Sponsors
collaborator

Mazandaran University of Medical Sciences

OTHER

lead

Nasim Tabrizi

OTHER

NCT05008354 - Effect of Pyridoxine on Behavioral Adverse Events of Levetiracetam | Biotech Hunter | Biotech Hunter